Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer

2 May 2022

Abstract excerpt

Background: Recent studies highlight the carcinogenesis role of SHC-adaptor protein 1 (SHC1) in cancer initiation, development, and progression. However, its aberrant expression, diagnostic and prognostic value remain unknown in a variety of tumors. Methods: The SHC1 expression profiles were analyzed using GTEx database, TCGA database, Oncomine and CPTAC database. The survival analysis was conducted using GEPIA2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35601500
DOI: 10.3389/fgene.2022.817118

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human CancerPMID 35601500Read ↗

Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment acrossmultiplecancersSemantic proximity Read ↗

SKP1: A novel target for prognosis predicting and precise treatment in human cancersSemantic proximity Read ↗

Integrated Multi-Omics Characterization of<em> WASHC2C</em> Reveals Tumor-Specific Molecular, Clinical, and Immunological Associations Across Human CancersSemantic proximity Read ↗

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-CancerSemantic proximity Read ↗

Identification of SHC2 as a prognostic biomarker: from pan-cancer analysis to colon adenocarcinoma validationSemantic proximity Read ↗

A comprehensive pan-cancer analysis identifies AP1S1 as a novel biomarker for predicting prognosis and immunotherapy responseSemantic proximity Read ↗

The Role of Shcbp1 in Signaling and DiseaseSemantic proximity Read ↗

Pan-cancer analysis of the prognostic and immunological roles of SHP-1/ptpn6Semantic proximity Read ↗

Associations of tumor suppressor SPARCL1 with cancer progression and prognosisSemantic proximity Read ↗

SCGB1A1 as a novel biomarker and promising therapeutic target for the management of HNSCCSemantic proximity Read ↗

Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activitySemantic proximity Read ↗

Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK PathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.